Skip to main content
Log in

Genetic polymorphism of CYP2D6 in Tamil population

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wolf, Smith G (1999) Pharmacogenetics. Br Med Bull 55: 366–386

    Article  CAS  PubMed  Google Scholar 

  2. He N, Daniel HI, Hajiloo L, Shockley D (1999) Dextromethorphan O-demethylation polymorphism in an African-American population. Eur J Clin Pharmacol 55: 457–459

    Article  CAS  PubMed  Google Scholar 

  3. Idle JR, Smith RL (1984) The debrisoquine hydroxylation gene: a gene of multiple consequences. In: Lemberger L, Reidenberg MM, Washington DC (eds) Proceedings of the Second World Conference of Clinical Pharmacology and Therapeutics, American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD, pp 148–164

    Google Scholar 

  4. Lamba V, Lamba JK, Dilawari JB, Kohli KK (1998) Genetic polymorphism of CYP2D6 in North Indian subjects. Eur J Clin Pharmacol 54: 787–7914

    Article  CAS  PubMed  Google Scholar 

  5. Mamidi RNVS, Satyavageeswaram S. Vakkalanka SVS, Chaluvadi MR, Katneni K, Brahmadevara N, Damodarram G, Subramaniam S (1999) Polymorphism of dextromethorphan oxidation in South Indian subjects. Clin Pharmacol Ther 66: 193–200

    Article  CAS  PubMed  Google Scholar 

  6. Abraham BK, Adithan C, Shashindran CH, Vasu S, Alekutty NA (2000) Genetic polymorphism of CYP2D6 in s Keralite (South India) population. Br J Clin Pharmac 49: 285–286

    Article  CAS  Google Scholar 

  7. Abraham BK, Adithan C, Kiran UP, Asad M, Koumaravelou K (2000) Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India. Acta Pharmacol Sin 21: 494–498

    CAS  PubMed  Google Scholar 

  8. Weesurya K, Jayakody RL, Smith AD, Wolf CR, Tucker GT, Lennard MS (1994) Debrisoquine and mephenytoin oxidation in Sinhalese: a population study. Br J Clin Pharmac 38: 466–470

    Article  Google Scholar 

  9. Tamminga WJ, Wermer J, Oosterhuis B, Wieling J, Wilffert B, de Leiji LFMH, et al (1999) CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences.Eur J Clin Pharmacol 55: 177–184

    Article  CAS  PubMed  Google Scholar 

  10. Lam YWF, Rodriguez SY (1993) High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther Drug Monit 15: 300–304

    Article  CAS  PubMed  Google Scholar 

  11. Schimid B, Bicher J, Preisig R, Kupfer A (1985) Polymorphic dextromethorphan metabolism: Cosegregation of oxidative O-demethylation with debrisoquine hydroxylation. Clin Pharmacol Ther 38: 618–624

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abraham, B., Adithan, C., Shashindran, C. et al. Genetic polymorphism of CYP2D6 in Tamil population. Eur J Clin Pharmacol 56, 849–850 (2001). https://doi.org/10.1007/s002280000231

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280000231

Navigation